Research Compound - Metabolic
Triple GLP-1/GIP/Glucagon Receptor Agonist
Retatrutide is a synthetic triple agonist of the GLP-1, GIP and glucagon receptors used as a research tool in studies investigating multi-receptor incretin signaling and energy metabolism pathways.
For research and scientific purposes only. Not intended for human therapeutic use, diagnosis, treatment or consumption of any kind.
Retatrutide is a synthetic triple agonist of the GLP-1, GIP and glucagon receptors used as a research tool in studies investigating multi-receptor incretin signaling and energy metabolism pathways.
Simultaneous activation of the GLP-1, GIP and glucagon receptors is studied in vitro and in vivo for its effects on receptor cross-talk and metabolic signaling pathways.
This material is intended solely for qualified laboratory research and analytical applications. It is not intended for human or veterinary use, clinical administration, diagnosis, treatment or prevention of any disease or condition.
10mg with 2ml yields an approximate concentration of 5mg/ml, and 20mg with 2ml yields an approximate concentration of 10mg/ml.
This vial contains 10 mg of peptide.
Manufactured under GMP conditions in certified South Korean facilities (ISO 9001 & 13485) and independently verified by HPLC to >99% purity on a batch-by-batch basis. Certificates of Analysis are available on request.
We ship across the European Union. Orders are processed within 1–2 business days and typically arrive within 3–5 business days to most EU destinations. All peptides are dispatched in secure packaging, with a tracking number sent once your order leaves our facility. Free shipping on orders over €199.
Retatrutide is a synthetic triple agonist of the GLP-1, GIP and glucagon receptors used as a research tool in studies investigating multi-receptor incretin signaling and energy metabolism pathways. It is supplied strictly for laboratory research and is not approved for human therapeutic use.
We ship across the European Union. Orders are processed within 1-2 business days and typically arrive within 3-5 business days to most EU destinations, dispatched in secure packaging.
Retatrutide is supplied as 10mg, Lyophilised Powder. 10mg with 2ml yields an approximate concentration of 5mg/ml, and 20mg with 2ml yields an approximate concentration of 10mg/ml.
Yes. All GENIQ compounds are manufactured under GMP conditions in ISO 9001 and 13485 certified facilities, and independently verified by HPLC to greater than 99% purity on a batch-by-batch basis. Certificates of Analysis are available on request.